Defining Factors that Influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2 in Asians
Preprint
- 8 March 2022
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Summary: The scale and duration of neutralizing antibody responses targeting SARS-CoV-2 viral variants represents a critically important serological parameter that predicts protective immunity for COVID-19. In this study, we present longitudinal data illustrating the impact of age, sex and comorbidities on the kinetics and strength of vaccine-induced neutralizing antibody responses for key variants in an Asian volunteer cohort. We demonstrate a reduction in neutralizing antibody titres across all groups six months post-vaccination and show a marked reduction in the serological binding and neutralizing response targeting Omicron compared to other viral variants. We also highlight the increase in cross-protective neutralizing antibody responses against Omicron induced by a third dose (booster) of vaccine. These data illustrate how key virological factors such as immune escape mutation combined with host factors such as age and sex of the vaccinated individuals influence the strength and duration of cross-protective serological immunity for COVID-19.Keywords
This publication has 37 references indexed in Scilit:
- Vaccine Breakthrough Infections with SARS-CoV-2 VariantsThe New England Journal of Medicine, 2021
- Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccineDiabetes/Metabolism Research and Reviews, 2021
- Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 studyNature Medicine, 2021
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunityCell, 2021
- SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targetseLife, 2021
- Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell FatesCell, 2020
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityScience, 2020
- Sequencing and cloning of antigen-specific antibodies from mouse memory B cellsNature Protocols, 2016
- Hybridoma Technology for the Generation of Rodent mAbs via Classical FusionMethods in Molecular Biology, 2014
- The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune responseThe EMBO Journal, 1997